Transcript of Earnings call recordings held on May 12, 2026
DRREDDY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Dr Reddy's Laboratories submitted the transcript of its Q4 and FY ended March 31, 2026 earnings call conducted on May 12, 2026. This is a regulatory filing under SEBI Listing Regulations, specifically Regulation 30. The filing is a cover letter transmitting the transcript document to the stock exchanges (NSE, BSE, NYSE, and NSE IFSC). The actual earnings call content and discussions are not included in this filing - they are available separately on the company's website. The transcript covers the company's quarterly and annual financial performance for investors and analysts.
This filing is informational in nature. The actual earnings call transcript contains management commentary and Q&A that may influence investor sentiment, but the substantive content is not contained in this disclosure. Shareholders seeking detailed financial guidance or outlook should access the full transcript on Dr Reddy's website.